Clinical Trials on Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors in Hong Kong

Total 8 results

  • Amgen
    Active, not recruiting
    AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).
    Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation
    Taiwan, Hong Kong
  • The University of Hong Kong
    Unknown
    Circulating Tumor Cells in mCRC for Liver Resection
    Metastatic Colorectal Cancer | Circulating Tumor Cell
    Hong Kong
  • Chinese University of Hong Kong
    Completed
    PET-CT and Circulating Tumor Cells in Colorectal Cancer
    Colorectal Cancer | Metastasis
    Hong Kong
  • Taiho Oncology, Inc.
    Completed
    A Study of TAS-120 in Patients With Advanced Solid Tumors
    Breast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors
    France, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
  • xCures
    Cancer Commons
    Available
    Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
    Melanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditions
    United States
  • Novartis Pharmaceuticals
    Recruiting
    Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation (KontRASt-01)
    Carcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | KRAS G12C Mutant Solid Tumors | Carcinoma, Colorectal
    United States, Japan, Australia, Germany, Italy, Spain, Canada, Denmark, Korea, Republic of, Taiwan, Belgium, Hong Kong, China, France, Singapore, Netherlands
  • NantCell, Inc.
    Takeda
    Terminated
    QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (GAMMA)
    Cancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine Cancer
    Italy, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more
  • Tempus AI
    GlaxoSmithKline
    Active, not recruiting
    Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors (PAVO)
    Melanoma | Head and Neck Cancer | Pancreatic Cancer | Esophageal Cancer | Solid Tumor | Metastatic Cancer | Endometrial Cancer | Urologic Cancer | Breast Tumor | Locally Advanced Solid Tumor | Lung Tumor | Colon Tumor, Malignant
    United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe